Seth Klarman · Q2 2018
Baupost Group
Portfolio at the end of Q2 2018, from the 13F filed August 13, 2018. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Twenty-First Century Fox FOXA · history | 17.1% | Q3 2015 | Add 48% |
| Synchrony SYF · history | 8.5% | Q3 2016 | No change |
| Cheniere Energy LNG · history | 8.1% | Q1 2014 | Reduce 32% |
| Viasat VSAT · history | 7.9% | Q2 2013 or earlier | Add 1% |
| Qorvo QRVO · history | 7.7% | Q1 2017 | No change |
| Allergan AGN · history | 7.2% | Q1 2016 | Add 4% |
| Pioneer Natural Resources PXD · history | 6.6% | Q3 2017 | No change |
| Twenty-First Century Fox FOX · history | 5.9% | Q3 2015 | Add 19% |
| Antero Resources AR · history | 5.0% | Q3 2014 | No change |
| DigitalBridge CLNY · history | 2.7% | Q2 2018 | Buy |
| Tesla TSLA.CV · convertible notes · history | 2.7% | Q1 2018 | Add 400% |
| AT&T T · history | 2.7% | Q2 2018 | Buy |
| Cardinal Health CAH · history | 2.2% | Q4 2016 | No change |
| Atara Biotherapeutics ATRA · history | 2.0% | Q4 2014 | No change |
| McKesson MCK · history | 1.9% | Q3 2017 | Add 1% |
| Theravance Biopharma TBPH · history | 1.8% | Q2 2014 | No change |
| PG&E PCG · history | 1.7% | Q1 2018 | Add 43% |
| Cencora COR · history | 1.4% | Q3 2017 | Add 42% |
| Veritiv VRTV · history | 1.3% | Q3 2014 | No change |
| Tribune Media TRCO · history | 1.0% | Q2 2018 | Buy |
| Keryx Biopharmaceuticals KERX · history | 0.8% | Q1 2014 | No change |
| Sinclair SBGI · history | 0.7% | Q2 2018 | Buy |
| AMC Entertainment AMC · history | 0.7% | Q3 2017 | No change |
| Novagold Resources NG · history | 0.5% | Q2 2013 or earlier | No change |
| GTY Technology GTYH.U · units · history | 0.4% | Q4 2016 | No change |
| Theravance Biopharma TBPH.CV · convertible notes · history | 0.3% | Q4 2016 | No change |
| Paratek Pharmaceuticals PRTK · history | 0.2% | Q4 2014 | No change |
| Translate Bio TBIO · history | 0.2% | Q2 2018 | Buy |
| Saban Capital Acquisition SCAC · history | 0.2% | Q4 2016 | No change |
| Trilogy Metals TMQ · history | 0.2% | Q2 2013 or earlier | Add 23% |
| Shire SHPG · history | 0.1% | Q2 2018 | Buy |
| Sentinel Energy Services STNL.U · units · history | 0.1% | Q4 2017 | No change |
| Saban Capital Acquisition SCAC.WS · warrants · history | 0.0% | Q4 2016 | No change |
| 33 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q1 2018, adjusted for stock splits.
Sector weighting
| Media & telecom | 36.0% | |
|---|---|---|
| Energy | 19.7% | |
| Health care | 18.2% | |
| Financials & real estate | 11.6% | |
| Technology | 8.1% | |
| Consumer discretionary | 2.7% | |
| Utilities | 1.7% | |
| Industrials | 1.3% | |
| Materials | 0.7% |
What changed from Q1 2018
- Buy DigitalBridge CLNY 2.7% of the 13F
- Buy AT&T T 2.7% of the 13F
- Buy Tribune Media TRCO 1.0% of the 13F
- Buy Sinclair SBGI 0.7% of the 13F
- Buy Translate Bio TBIO 0.2% of the 13F
- Buy Shire SHPG 0.1% of the 13F
- Add 48% Twenty-First Century Fox FOXA 9.4% → 17.1%
- Add 1% Viasat VSAT 8.7% → 7.9%
- Add 4% Allergan AGN 7.7% → 7.2%
- Add 19% Twenty-First Century Fox FOX 4.0% → 5.9%
- Add 400% Tesla TSLA.CV 0.5% → 2.7%
- Add 1% McKesson MCK 2.2% → 1.9%
- Add 43% PG&E PCG 1.3% → 1.7%
- Add 42% Cencora COR 1.1% → 1.4%
- Add 23% Trilogy Metals TMQ 0.1% → 0.2%
- Reduce 32% Cheniere Energy LNG 10.7% → 8.1%
- Sell Time Warner TWX was 7.4%
- Sell Colony NorthStar CLNS was 2.7%
- Sell PBF Energy PBF was 2.6%
- Sell ChipMOS IMOS was 0.1%
- Sell Forward Pharma FWP was 0.1%
- Sell Orexigen Therapeutics OREX was 0.0%